Marshall University innovators selected for prestigious NIH-funded entrepreneurship program
2024-08-21
(Press-News.org) HUNTINGTON, W.Va. – Two Marshall University innovators, Brad Profitt, DC, DPT, DScPT, and M’Hamed Turki, M.D., have been selected to participate in the National Institutes of Health (NIH) funded IDeA Regional Entrepreneurship Development (I-RED) Program, facilitated by the XLerator Network.
The NIH’s competitive I-RED program supports the creation of educational products to promote entrepreneurship in academic institutions. XLerator Health, a health care accelerator based in Louisville, Kentucky, assists startup founders like Profitt and Turki in commercializing their businesses and attracting funding.
Profitt is a co-founder of Ortho-HAB, LLC and an associate professor at the Marshall University School of Physical Therapy. He has developed KneeXT, a groundbreaking medical device designed to aid in the recovery of knee extension and flexion post trauma, injury or surgery. This innovative technology is designed to restore functional range of motion, enhancing patient outcomes and rehabilitation by complementing the work of the physical therapist in the clinic and empowering patients to take an active role in their recovery at home. As part of his I-RED project, Profitt aims to leverage the expertise of seasoned professionals to bring the device to market, ultimately placing it in the hands of patients.
Turki, a gastroenterology fellow at the Marshall University Joan C. Edwards School of Medicine, has invented an oropharyngeal cannula that attaches to a bite guard. This device facilitates the passage of endoscopes and helps prevent hypoxia during upper endoscopies, enhancing patient safety and procedural efficiency. Initial prototypes have been designed and developed exclusively in West Virginia, in collaboration with Intermed Labs. The oropharyngeal cannula has recently entered the human clinical trial stage under Marshall University IRB Study #2182501-2. Through the I-RED program, Turki plans to transition the device from the lab to the market, effectively addressing a specific patient need.
Profitt and Turki are two of 20 participants across eight teams selected to participate in the 2024 I-RED program.
These selections highlight Marshall University’s commitment to fostering research and innovation across the health sciences that advances technologies and contributes to the future of medical science.
###
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2024-08-21
New Rochelle, NY, August 21, 2024—Researchers from the University of Pennsylvania, Perelman School of Medicine, Gene Therapy Program, and Moderna, have shown that repeated administration of lipid nanoparticle-encapsulated mRNA therapy significantly extended survival and reduced serum leucine levels in a mouse model of maple syrup urine disease (MSUD). Click here to read the article now.
The researchers, led by James Wilson, M.D., Ph.D., from the University of Pennsylvania, Perelman School of Medicine, evaluated a lipid nanoparticle-based treatment approach to address all possible genetic mutations that can cause MSUD.
“Repeated intravenous ...
2024-08-21
A U.S. Army Medical Materiel Development Activity commercial partner received Emergency Use Authorization from the U.S. Food and Drug Administration for the Department of Defense to use octaplasLG Powder—a potentially lifesaving treatment option for blood replacement therapies in certain operational circumstances. Notice of the EUA for this product was received by the company, Octapharma USA, on Aug. 8, 2024.
USAMMDA’s Warfighter Protection and Acute Care Project Management Office, which has a Cooperative Research and Development Agreement with Octapharma USA, manages research and development efforts for several ...
2024-08-21
Pennington Biomedical Research Center’s Dr. Candida Rebello wants to know more about the intersection of blood sugar levels and a diet rich in soy. This intersection is the primary focus of her new study, “Lifestyle Intervention for Improving Metabolic and Motivational Outcomes,” or MOTIVATE, which explores how specific diets can impact blood sugar, and potentially improve mood and energy levels.
When soy seeds are cut, they produce the anti-microbial compound known as glyceollin, which has been shown to improve insulin sensitivity and cognition. The cut soy seeds will be milled into flour and will be included in the diets of some of the participants. The MOTIVATE ...
2024-08-21
When UC San Francisco research showed that routinely treating children in Sub-Saharan Africa with a common antibiotic could reduce deaths in children under five, the World Health Organization (WHO) moved quickly to recommend the treatment – but only for infants between 1 and 11 months old.
Now, UCSF researchers have shown that treating babies is not enough. The antibiotic must be given to all children up to 5 years old to realize its full benefit, which is considerable: It lowers child mortality ...
2024-08-21
RESEARCH SUMMARY
Study Title: Belzutifan Versus Everolimus for Advanced Renal-Cell Carcinoma
Publication: New England Journal of Medicine, August 22, 2024
Dana-Farber Cancer Institute authors: Toni K. Choueiri, MD
Summary: The LITESPARK-005 phase 3 clinical enrolled 746 patients with metastatic clear cell renal cell carcinoma (ccRCC) who had progressed after treatment with both an immune checkpoint inhibitor (ICI) and an anti-angiogenic therapy. Patients were randomized to receive treatment with either belzutifan, a HIF-2α inhibitor, or everolimus. Overabundant HIF-2α is associated with increased cancer-driving activity. At the second interim analysis of this study, ...
2024-08-21
When you get infected with a virus, some of the first weapons your body deploys to fight it were passed down to us from our microbial ancestors billions of years ago. According to new research from The University of Texas at Austin, two key elements of our innate immune system came from a group of microbes called Asgard archaea.
Specifically, viperins and argonautes, two proteins that are known to play important roles in the immune systems of all complex life — from insects to plants to humans — came from the Asgard archaea. Versions of these defense proteins are also present in bacteria, but the versions in complex life forms are ...
2024-08-21
(Santa Barbara, Calif.) — UC Santa Barbara professors Andrew Jayich and Jon Schuller have been selected by the Gordon and Betty Moore Foundation to be part of the 2024 cohort of Experimental Physics Investigators. They join 17 other mid-career researchers from around the country, each receiving a five-year, $1.25 million grant to pursue research goals.
“This initiative is designed to support novel and potentially high-payoff projects that will advance the field of physics but might be hard to fund through traditional funding sources,” said Theodore ...
2024-08-21
In the first 24 hours after a python devours its massive prey, its heart grows 25%, its cardiac tissue softens dramatically, and the organ squeezes harder and harder to more than double its pulse. Meanwhile, a vast collection of specialized genes kicks into action to help boost the snake’s metabolism fortyfold. Two weeks later, after its feast has been digested, all systems return to normal—its heart remaining just slightly larger, and even stronger, than before.
This extraordinary process, described by CU Boulder researchers this week in the journal PNAS, could ultimately inspire novel treatments for a common human heart condition called cardiac fibrosis, in which ...
2024-08-21
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, AUGUST 21, 2024
MINNEAPOLIS – Contrary to previous research, a new study of female participants finds no link between migraine and the risk of developing Parkinson’s disease. The study is published in the August 21, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
“These results are reassuring for women who have migraine, which itself causes many burdens, that they don’t have to worry about an increased risk ...
2024-08-21
Neuroticism may moderate the relationship between certain personality traits and self-control, and the interaction effects appear to differ by the type of self-control, according to a study published August 21, 2024 in the open-access journal PLOS ONE by Fredrik Nilsen from the University of Oslo and the Norwegian Defence University, Norway, and colleagues.
Self-control is important for mental and physical health, and certain personality traits are linked to the trait. Previous studies suggest that conscientiousness and extraversion enhance self-control, whereas neuroticism hampers it. However, the link between personality ...
LAST 30 PRESS RELEASES:
[Press-News.org] Marshall University innovators selected for prestigious NIH-funded entrepreneurship program
